{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:50:34Z","timestamp":1790142634567,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.amjcard.2025.05.029","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:23:52Z","timestamp":1748892232000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Bridging Gaps in LDL-C Management: Utilization of Lipid-Lowering Therapies, Gender Disparities, and the Impact of Cardiology Visits on Secondary Prevention"],"prefix":"10.1016","volume":"253","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6919-0459","authenticated-orcid":false,"given":"Surik","family":"Sedrakyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilawal","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Gaughran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Sinauridze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Georgy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hurley","family":"Sally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uyen","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.amjcard.2025.05.029_bib0001","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood Cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.05.029_bib0002","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2019.03.014","article-title":"Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries","volume":"285","author":"De Backer","year":"2019","journal-title":"Atherosclerosis"},{"issue":"16","key":"10.1016\/j.amjcard.2025.05.029_bib0003","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"ORION-10 and ORION-11 investigators. Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2025.05.029_bib0004","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"9B","key":"10.1016\/j.amjcard.2025.05.029_bib0005","doi-asserted-by":"crossref","first-page":"30F","DOI":"10.1016\/S0002-9149(99)00270-2","article-title":"Role of fibrates in the management of hypertriglyceridemia","volume":"83","author":"Rader","year":"1999","journal-title":"Am J Cardiol"},{"issue":"25","key":"10.1016\/j.amjcard.2025.05.029_bib0006","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.108.789800","article-title":"Get with the guidelines steering committee and investigators. Sex differences in medical care and early death after acute myocardial infarction","volume":"118","author":"Jneid","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.05.029_bib0007","series-title":"The Commonwealth Fund 2023 scorecard on State health system performance: Americans\u2019 Health declines and access to reproductive care shrinks, but states have options (Commonwealth Fund)","author":"Radley","year":"2023"},{"issue":"2","key":"10.1016\/j.amjcard.2025.05.029_bib0008","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijrobp.2021.08.007","article-title":"Logistic regression in clinical studies","volume":"112","author":"Zabor","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"20","key":"10.1016\/j.amjcard.2025.05.029_bib0009","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.jacc.2019.10.009","article-title":"The Global burden of cardiovascular diseases and Risk factors: 2020 and beyond","volume":"74","author":"Mensah","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2025.05.029_bib0010","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijcard.2020.06.059","article-title":"Suboptimal management of dyslipidemia in everyday clinical practice: alarming signals from real-world data","volume":"316","author":"Athyros","year":"2020","journal-title":"Int J Cardiol"},{"issue":"10059","key":"10.1016\/j.amjcard.2025.05.029_bib0011","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.amjcard.2025.05.029_bib0012","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40256-019-00379-9","article-title":"Lipid-lowering efficacy of Ezetimibe in patients with atherosclerotic cardiovascular disease: a systematic review and meta-analyses","volume":"20","author":"Shaya","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"issue":"18","key":"10.1016\/j.amjcard.2025.05.029_bib0013","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER steering committee and investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.amjcard.2025.05.029_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019331","article-title":"Adoption of PCSK9 inhibitors among patients with atherosclerotic disease","volume":"10","author":"Dayoub","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"10.1016\/j.amjcard.2025.05.029_bib0015","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.3390\/jcm10173828","article-title":"Trends in PCSK9 inhibitor prescriptions before and after the price reduction in patients with atherosclerotic cardiovascular disease","volume":"10","author":"Smith","year":"2021","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.amjcard.2025.05.029_bib0016","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/jamacardio.2023.5155","article-title":"Impact of bempedoic acid on total cardiovascular events: a prespecified analysis of the CLEAR outcomes randomized clinical trial","volume":"9","author":"Nicholls","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.amjcard.2025.05.029_bib0017","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/2047487319864671","article-title":"Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy","volume":"27","author":"Ballantyne","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.amjcard.2025.05.029_bib0018","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC Scientific Document Group. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.amjcard.2025.05.029_bib0019","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.maturitas.2009.02.014","article-title":"Risk factors for cardiovascular disease in women","volume":"63","author":"Schenck-Gustafsson","year":"2009","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.amjcard.2025.05.029_bib0020","doi-asserted-by":"crossref","first-page":"bqad079","DOI":"10.1210\/endocr\/bqad079","article-title":"Estrogen and the vascular endothelium: the unanswered questions","volume":"164","author":"SenthilKumar","year":"2023","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.amjcard.2025.05.029_bib0021","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5202","article-title":"Participation of women and older participants in randomized clinical trials of lipid-lowering therapies: a systematic review","volume":"3","author":"Khan","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"9602","key":"10.1016\/j.amjcard.2025.05.029_bib0022","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Prospective Studies","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2025.05.029_bib0023","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2147\/PPA.S260562","article-title":"Interventions to improve adherence to cardiovascular medication: what about gender differences? A systematic literature review","volume":"14","author":"Vervloet","year":"2020","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"10.1016\/j.amjcard.2025.05.029_bib0024","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacl.2016.02.016","article-title":"Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study","volume":"10","author":"Karalis","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.amjcard.2025.05.029_bib0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients \u2014The PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"10.1016\/j.amjcard.2025.05.029_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062158","article-title":"Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.amjcard.2025.05.029_bib0027","doi-asserted-by":"crossref","first-page":"914.e5","DOI":"10.1016\/j.amjmed.2015.02.013","article-title":"The new lipid guidelines: what do primary care clinicians think?","volume":"128","author":"Jam\u00e9","year":"2015","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.amjcard.2025.05.029_bib0028","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/clc.23911","article-title":"Cardiac rehabilitation: effective yet underutilized in patients with cardiovascular disease","volume":"45","author":"Bracewell","year":"2022","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2025.05.029_bib0029","doi-asserted-by":"crossref","unstructured":"Beatty AL, Beckie TM, Dodson J, Goldstein CM, Hughes JW, Kraus WE, Martin SS, Olson TP, Pack QR, Stolp H, Thomas RJ, Wu WC, Franklin BA. A new era in cardiac rehabilitation delivery: research gaps, questions, strategies, and priorities. Circulation. 2023;147(3):254\u2013266. doi: 10.1161\/CIRCULATIONAHA.122.061046.","DOI":"10.1161\/CIRCULATIONAHA.122.061046"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925003418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925003418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T12:20:46Z","timestamp":1758543646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914925003418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":29,"alternative-id":["S0002914925003418"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.05.029","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging Gaps in LDL-C Management: Utilization of Lipid-Lowering Therapies, Gender Disparities, and the Impact of Cardiology Visits on Secondary Prevention","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}